IMC Priora is proud to be at the forefront of medical innovation in Croatia, and the use of these robots is just one example of the hospital’s commitment to providing cutting-edge care.
Prostate cancer is a significant health challenge, with a high incidence in both the Europe and Croatia. IMC Priora is joining the fight against prostate cancer with the implementation of the latest technology such as the Da Vinci Xi surgical robot and the pioneering Mona Lisa Dx biopsy robot. Their integration marks a key step towards significant progress in patient care.
International Medical Center Priora is the first in Croatia to introduce the latest global methods for the early detection and treatment of prostate cancer. Under the leadership of the esteemed Mr. Sc. Tomislav Kalem, Dr. Med., who is known for his extensive experience in Germany and serves as Director and Head of the Department of Urology, IMC Priora stands out as a leader in the implementation of the most modern global methods in surgical robotics.
The use of these advanced technologies allows surgeons to have significantly greater precision and control during procedures, while providing patients with a less invasive procedure, easier and faster recovery, and minimizes the risk of infections and complications.
Precise diagnosis is the foundation of an individualized approach to treatment for each patient.
Fusion biopsy with the help of the Mona Lisa robot opens a new chapter of precise diagnostics – a key aspect of early intervention. Detailed planning plays an important role in every therapy, and careful anamnesis and diagnosis are the basis for an individual concept for further treatment.
Diagnosed prostate cancer is an operable tumor, and the procedure performed with the help of the Da Vinci Xi surgical robotics system provides surgeons with unparalleled precision and control during surgery, thereby reducing the likelihood of complications and ensuring a faster and less painful recovery for the patient.
At IMC Priora, operations using the Da Vinci Xi robotic surgical system will be carried out under the constant guidance and mentorship of renowned experts from Munich, especially Georg Schoen, MD.
Dr. Schoen, a highly respected urology specialist with extensive academic and professional experience, who has performed over 5,000 operations using the Da Vinci robotic surgical system, will oversee the training of new staff and future surgeons, including Dr. Tomislav Kalem.
These advanced tools are used by medical professionals to optimize treatment outcomes, highlighting our commitment to excellence in patient care and medical innovation.
